There have been several major accomplishments within the past fiscal year. Neuromodulation of neural networks, whereby a selected circuit is regulated by a particular modulator, plays a critical role in learning and memory. Among neuromodulators, acetylcholine (ACh) plays a critical role in hippocampus-dependent memory and has been shown to modulate neuronal circuits in the hippocampus. However, it has remained unknown how ACh modulates hippocampal output. Here, using in vitro and in vivo approaches, we show that ACh, by activating oriens lacunosum moleculare (OLM) interneurons and therefore augmenting the negative-feedback regulation to the CA1 pyramidal neurons, suppresses the circuit from the hippocampal area CA1 to the deep-layer entorhinal cortex (EC). We also demonstrate, using mouse behavior studies, that the ablation of OLM interneurons specifically impairs hippocampus-dependent but not hippocampus-independent learning. These data suggest that ACh plays an important role in regulating hippocampal output to the EC by activating OLM interneurons, which is critical for the formation of hippocampus-dependent memory. In addition, although much progress has been made in understanding type II theta rhythm generation under urethane anesthesia, less is known about the mechanisms underlying type I theta generation during active exploration. To better understand the contributions of cholinergic and NMDA receptor activation to type I theta generation, we recorded hippocampal theta oscillations from freely moving mice with local infusion of cholinergic or NMDA receptor antagonists to either the hippocampus or the entorhinal cortex (EC). We found that cholinergic receptors in the hippocampus, but not the EC, and NMDA receptors in the EC, but not the hippocampus, are critical for open-field theta generation and Y-maze performance. We further found that muscarinic M1 receptors located on pyramidal neurons, but not interneurons, are critical for cholinergic modulation of hippocampal synapses, theta generation, and Y-maze performance. These results suggest that hippocampus and EC neurons recruit cholinergic-dependent and NMDA-receptor-dependent mechanisms, respectively, to generate theta oscillations to support behavioral performance.

Project Start
Project End
Budget Start
Budget End
Support Year
23
Fiscal Year
2019
Total Cost
Indirect Cost
City
State
Country
Zip Code
Haam, Juhee; Zhou, Jingheng; Cui, Guohong et al. (2018) Septal cholinergic neurons gate hippocampal output to entorhinal cortex via oriens lacunosum moleculare interneurons. Proc Natl Acad Sci U S A 115:E1886-E1895
Fitch, Richard W; Snider, Barry B; Zhou, Quan et al. (2018) Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine. J Nat Prod 81:1029-1035
Gu, Zhenglin; Yakel, Jerrel L (2017) Inducing theta oscillations in the entorhinal hippocampal network in vitro. Brain Struct Funct 222:943-955
Gu, Zhenglin; Alexander, Georgia M; Dudek, Serena M et al. (2017) Hippocampus and Entorhinal Cortex Recruit Cholinergic and NMDA Receptors Separately to Generate Hippocampal Theta Oscillations. Cell Rep 21:3585-3595
Haam, Juhee; Yakel, Jerrel L (2017) Cholinergic modulation of the hippocampal region and memory function. J Neurochem 142 Suppl 2:111-121
Lewis, Jeanne A; Yakel, Jerrel L; Pandya, Anshul A (2017) Levamisole: A Positive Allosteric Modulator for the ?3?4 Nicotinic Acetylcholine Receptors Prevents Weight Gain in the CD-1 Mice on a High Fat Diet. Curr Pharm Des 23:1869-1872
Wu, Jie; Liu, Qiang; Tang, Pei et al. (2016) Heteromeric ?7?2 Nicotinic Acetylcholine Receptors in the Brain. Trends Pharmacol Sci 37:562-574
Damborsky, Joanne C; Smith, Kathleen G; Jensen, Patricia et al. (2016) Local cholinergic-GABAergic circuitry within the basal forebrain is modulated by galanin. Brain Struct Funct :
Dineley, Kelly T; Pandya, Anshul A; Yakel, Jerrel L (2015) Nicotinic ACh receptors as therapeutic targets in CNS disorders. Trends Pharmacol Sci 36:96-108
Cheng, Qing; Yakel, Jerrel L (2015) The effect of ?7 nicotinic receptor activation on glutamatergic transmission in the hippocampus. Biochem Pharmacol 97:439-444

Showing the most recent 10 out of 40 publications